169 related articles for article (PubMed ID: 15549298)
21. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain.
Lavisse S; Inoue K; Jan C; Peyronneau MA; Petit F; Goutal S; Dauguet J; Guillermier M; Dollé F; Rbah-Vidal L; Van Camp N; Aron-Badin R; Remy P; Hantraye P
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):478-94. PubMed ID: 25488184
[TBL] [Abstract][Full Text] [Related]
22. Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease.
Ramlackhansingh AF; Bose SK; Ahmed I; Turkheimer FE; Pavese N; Brooks DJ
Neurology; 2011 May; 76(21):1811-6. PubMed ID: 21606452
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.
Syvänen S; Eriksson J; Genchel T; Lindhe O; Antoni G; Långström B
BMC Med Imaging; 2007 Jul; 7():6. PubMed ID: 17663770
[TBL] [Abstract][Full Text] [Related]
24. Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography.
Ishiwata K; Wang WF; Kimura Y; Kawamura K; Ishii K
Ann Nucl Med; 2003 May; 17(3):205-11. PubMed ID: 12846542
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and preclinical evaluation of 2-(2-furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET tracer for the imaging of cerebral adenosine A2A receptors.
Zhou X; Khanapur S; Huizing AP; Zijlma R; Schepers M; Dierckx RA; van Waarde A; de Vries EF; Elsinga PH
J Med Chem; 2014 Nov; 57(21):9204-10. PubMed ID: 25279444
[TBL] [Abstract][Full Text] [Related]
26. Binding of tritiated and radioiodinated ZM241,385 to brain A2A adenosine receptors.
Sihver W; Bier D; Holschbach MH; Schulze A; Wutz W; Olsson RA; Coenen HH
Nucl Med Biol; 2004 Feb; 31(2):173-7. PubMed ID: 15013482
[TBL] [Abstract][Full Text] [Related]
27. [In vivo investigation of the A2A adenosine receptor distribution using the [11C]-CSC radioligand].
Boros I; Lengyel Z; Balkay L; Horváth G; Szentmiklósi AJ; Fekete I; Márián T
Orv Hetil; 2002 May; 143(21 Suppl 3):1317-9. PubMed ID: 12077927
[TBL] [Abstract][Full Text] [Related]
28. Adenosine A
Marques TR; Natesan S; Rabiner EA; Searle GE; Gunn R; Howes OD; Kapur S
Psychopharmacology (Berl); 2022 Nov; 239(11):3439-3445. PubMed ID: 34175983
[TBL] [Abstract][Full Text] [Related]
29. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
[TBL] [Abstract][Full Text] [Related]
30. Age-related changes of the [11C]CFT binding to the striatal dopamine transporters in the Fischer 344 rats: a PET study.
Kawamura K; Oda K; Ishiwata K
Ann Nucl Med; 2003 May; 17(3):249-53. PubMed ID: 12846549
[TBL] [Abstract][Full Text] [Related]
31. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements.
Zoghbi SS; Shetty HU; Ichise M; Fujita M; Imaizumi M; Liow JS; Shah J; Musachio JL; Pike VW; Innis RB
J Nucl Med; 2006 Mar; 47(3):520-7. PubMed ID: 16513622
[TBL] [Abstract][Full Text] [Related]
32. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.
Honer M; Brühlmeier M; Missimer J; Schubiger AP; Ametamey SM
J Nucl Med; 2004 Mar; 45(3):464-70. PubMed ID: 15001689
[TBL] [Abstract][Full Text] [Related]
33.
Vuorimaa A; Rissanen E; Airas L
Contrast Media Mol Imaging; 2017; 2017():6975841. PubMed ID: 29348737
[TBL] [Abstract][Full Text] [Related]
34. Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A(2A) receptors with positron emission tomography.
Wang WF; Ishiwata K; Nonaka H; Ishii S; Kiyosawa M; Shimada J; Suzuki F; Senda M
Nucl Med Biol; 2000 Aug; 27(6):541-6. PubMed ID: 11056367
[TBL] [Abstract][Full Text] [Related]
35. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
37. Potential of [11C]TMSX for the evaluation of adenosine A2A receptors in the skeletal muscle by positron emission tomography.
Ishiwata K; Mizuno M; Kimura Y; Kawamura K; Oda K; Sasaki T; Nakamura Y; Muraoka I; Ishii K
Nucl Med Biol; 2004 Oct; 31(7):949-56. PubMed ID: 15464397
[TBL] [Abstract][Full Text] [Related]
38. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist.
Ishiwata K; Noguchi J; Toyama H; Sakiyama Y; Koike N; Ishii S; Oda K; Endo K; Suzuki F; Senda M
Appl Radiat Isot; 1996; 47(5-6):507-11. PubMed ID: 8673072
[TBL] [Abstract][Full Text] [Related]
40. 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.
Horti AG; Fan H; Kuwabara H; Hilton J; Ravert HT; Holt DP; Alexander M; Kumar A; Rahmim A; Scheffel U; Wong DF; Dannals RF
J Nucl Med; 2006 Oct; 47(10):1689-96. PubMed ID: 17015906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
